CDMOs in the biomanufacturing industry need to embrace digital tools and technologies to meet the demands of biotech partners.The reliance on paper-based and disparate systems slows down operations, creates frustrations, and adds the risk of manual errors.Integrated systems and digital transformation are crucial for eliminating redundancies, streamlining operations, and enabling faster tech transfers.The cost of not investing in digital change includes missed opportunities, stalled growth, and increased operational costs.